The
generic EpiPen is
already causing some insurance companies to
drop the
real one
/https%3A%2F%2Fblueprint-api-production.s3.amazonaws.com%2Fuploads%2Fcard%2Fimage%2F346832%2F31ec506b-1128-458d-9433-e932b9809507.jpg)
The introduction of a
generic version of the life-saving — and expensive —
EpiPen was heralded as a long overdue fix. But the move is **w
causing some insurance companies to change how they approach coverage of the allergy tool.*
The insurer Cigna on Thursday
said the company would ** longer cover the full-price EpiPen, which costs as much as $600. Those prices
sparked outrage last summer when customers with high-deductible healthcare plans were caught off guard by the high prices for a once-reasonable healthcare need. The pharmaceutical company Mylan bought the rights to the
EpiPen in 2007 and systematically raised the allergy tool's prices over the following nine years.*
Read more...
More about
Cvs,
Healthcare And Medicine,
Mylan,
Epipen, and
Business